Outset Medical, Inc.

Equities

OM

US6901451079

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
2.63 ^USD	+9.58%		+12.39%	-51.39%

Apr. 17	Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S	CI
Apr. 08	BTIG Initiates Outset Medical at Buy Rating With $6 Price Target	MT

Outset Medical, Inc. Provides Revenue Guidance for the Year 2024

January 08, 2024 at 08:40 am EST

Outset Medical, Inc. provided revenue guidance for the year 2024. For the year, the company expects revenue to be between $145 million to $153 million, growing 12% to 18% over unaudited revenue for 2023 based on the assumptions previously disclosed.

Latest news about Outset Medical, Inc.

Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S	Apr. 17	CI
BTIG Initiates Outset Medical at Buy Rating With $6 Price Target	Apr. 08	MT
Outset Medical, Inc. Announces Board Changes	Mar. 13	CI
RBC Reduces Price Target on Outset Medical to $5 From $6, Keeps Sector Perform Rating	Feb. 22	MT
Transcript : Outset Medical, Inc., Q4 2023 Earnings Call, Feb 21, 2024	Feb. 21
Earnings Flash (OM) OUTSET MEDICAL Reports Q4 Revenue $30.5M, vs. Street Est of $30.1M	Feb. 21	MT
Outset Medical, Inc. Announces Departure of Steve Williamson as Chief Commercial Officer, Effective March 1, 2024	Feb. 21	CI
Outset Medical, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 21	CI
Outset Medical, Inc. Reaffirms Earnings Guidance for 2024	Feb. 21	CI
North American Morning Briefing : Stock Futures -2-	Jan. 16	DJ
Outset Medical Shares Drop After RBC Downgrade	Jan. 12	MT
RBC Downgrades Outset Medical to Sector Perform From Outperform, Slashes Price Target to $6 From $14	Jan. 12	MT
Transcript : Outset Medical, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 05:15 PM	Jan. 08
Outset Medical, Inc. Provides Revenue Guidance for the Year 2024	Jan. 08	CI
Outset Medical, Inc.(NasdaqGS:OM) dropped from S&P Healthcare Equipment Select Industry Index	Dec. 18	CI
Transcript : Outset Medical, Inc. Presents at Bank of America Virtual Home Care Conference 2023, Dec-04-2023 03:00 PM	Dec. 04
Morgan Stanley Raises Outset Medical Price Target to $5.50 From $5, Maintains Equal Weight Rating	Dec. 04	MT
Morgan Stanley Cuts Price Target on Outset Medical to $5 From $19, Maintains Equalweight Rating	Nov. 14	MT
Transcript : Outset Medical, Inc., Q3 2023 Earnings Call, Nov 07, 2023	Nov. 07
Earnings Flash (OM) OUTSET MEDICAL Posts Q3 Revenue $30.4M, vs. Street Est of $30.4M	Nov. 07	MT
Outset Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
North American Morning Briefing : Middle-East -2-	23-10-16	DJ
US Equity Markets Close Mixed Friday Amid Banking Sector's Upbeat Earnings	23-10-13	MT
Sector Update: Health Care Stocks Advance in Late Afternoon	23-10-13	MT
Top Midday Decliners	23-10-13	MT

Chart Outset Medical, Inc.

Duration

Period

More charts

Company Profile

Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-08 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Outset Medical, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.63 USD

Average target price

5.786 USD

Spread / Average Target

+119.99%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
OUTSET MEDICAL, INC.	-51.39%	136M
THERMO FISHER SCIENTIFIC	+8.69%	220B
DANAHER CORPORATION	+6.69%	183B
INTUITIVE SURGICAL, INC.	+10.90%	133B
BOSTON SCIENTIFIC CORPORATION	+25.41%	107B
SIEMENS HEALTHINEERS AG	-0.72%	63.05B
EDWARDS LIFESCIENCES CORPORATION	+12.72%	51.74B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.96%	50.47B
AGILENT TECHNOLOGIES, INC.	+0.40%	40.91B
GE HEALTHCARE TECHNOLOGIES INC.	+15.03%	40.59B

Other Advanced Medical Equipment & Technology